MedPath

Managing Rumination and Worry: A pilot trial of an internet delivered intervention targeting repetitive negative thinking.

Not Applicable
Completed
Conditions
Depression
Anxiety
Mental Health - Anxiety
Mental Health - Depression
Registration Number
ACTRN12619001535167
Lead Sponsor
niversity of New South Wales
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
26
Inclusion Criteria

* Score above 27 on Repetitive Negative Thinking Questionnaire.
* Australian resident status
* At least 18 years of age
* Access to a computer, printer, and the internet
* If taking medication, must have been taking the same dose for at least 2 months and not intend to change that dose during the course of the program.
* Prepared to provide name, phone number, and address, and to provide the name and phone number of a local general practitioner.
* Willing to provide informed consent.

Exclusion Criteria

- Currently experiencing severe depression symptoms (score of 23 or above on the PHQ-9).
- Regularly using illicit drugs or regularly consuming more than three standard drinks per day
- Current regular use of benzodiazepines
- Current use of atypical anti-psychotics
- Currently experiencing a psychotic mental illness or bipolar disorder
- Completed an online program for depression and/or anxiety in the past year
- Currently suicidal and/or severe symptoms of suicidal ideation (defined as responding 3 to the PHQ-9 question 9 item that assesses the frequency of suicidal ideation over the past fortnight).
-Those scoring 1 or 2 on the Patient Health Questionnaire-9 Item (PHQ-9) item 9 will require risk assessment with the responsible clinician before being admitted into the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Changes in repetitive negative thinking symptoms according to mean scores on the Repetitive Thinking Questionnaire- Repetitive Negative Thinking Subscale (RNT)[Baseline, before each lesson, one week post-treatment (week 7), and at 1-month post-treatment (week 11). Primary time-point is post-treatment (week 7).];Changes in depression symptoms (according to mean scores on the Patient Health Questionnaire (PHQ-9)[Baseline, before each lesson, one week post-treatment (week 7), and at 1-month post-treatment (week 11). Primary time-point is post-treatment (week 7).];Changes in anxiety symptoms according to mean scores on the Generalised Anxiety Disorder 7-item scale (GAD-7).[Baseline, before each lesson, one week post-treatment (week 7), and at 1-month post-treatment (week 11). Primary time-point is post-treatment (week 7).]
Secondary Outcome Measures
NameTimeMethod
Changes in psychological distress according to mean scores on the Kessler-10 (K10).[Baseline, before each lesson, one week post-treatment (week 7), and at 1-month post-treatment (week 11). Primary time-point is post-treatment (week 7).];Treatment Satisfaction according to the scores on the Treatment Satisfaction Questionnaire.[One week post-treatment (week 7).];Adherence, according to the number of lessons completed, and the number who complete 100% of the complete 3-lesson program within the 6-week treatment period.[One week post-treatment (Week 7)];Changes in metacognitive beliefs (both positive and negative) about RNT according to mean scores on the Metacognitions Questionnaire-30 (MCQ-30). [Baseline and 1-month follow up (Week 11)]
© Copyright 2025. All Rights Reserved by MedPath